{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:03:02Z","timestamp":1792512182937,"version":"4.5.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00280-021-04335-w","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T10:11:13Z","timestamp":1627294273000},"page":"565-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment"],"prefix":"10.1007","volume":"88","author":[{"given":"Neha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-4063","authenticated-orcid":false,"given":"Saurabh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"4335_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-012-4128-7","volume":"95","author":"S Chandra","year":"2012","unstructured":"Chandra S (2012) Endophytic fungi: novel sources of anticancer lead molecules. Appl Microbiol Biotechnol 95:47\u201359. https:\/\/doi.org\/10.1007\/s00253-012-4128-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"4335_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G (2009) Amino acids: metabolism, functions, and nutrition. Amino Acids 37:1\u201317. https:\/\/doi.org\/10.1007\/s00726-009-0269-0","journal-title":"Amino Acids"},{"key":"4335_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.vph.2018.11.001","volume":"112","author":"RE Oberkersch","year":"2019","unstructured":"Oberkersch RE, Santoro MM (2019) Role of amino acid metabolism in angiogenesis. Vascul Pharmacol 112:17\u201323. https:\/\/doi.org\/10.1016\/j.vph.2018.11.001","journal-title":"Vascul Pharmacol"},{"key":"4335_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbcan.2012.07.001","volume":"1826","author":"P Icard","year":"2012","unstructured":"Icard P, Lincet H (2012) A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochim Biophys Acta Rev Cancer 1826:423\u2013433. https:\/\/doi.org\/10.1016\/j.bbcan.2012.07.001","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4335_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","volume":"22","author":"MJ Lukey","year":"2017","unstructured":"Lukey MJ, Katt WP, Cerione RA (2017) Targeting amino acid metabolism for cancer therapy. Drug Discov 22:796\u2013804. https:\/\/doi.org\/10.1016\/j.drudis.2016.12.003","journal-title":"Drug Discov"},{"key":"4335_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1054\/bjoc.2000.1353","volume":"83","author":"L Scott","year":"2000","unstructured":"Scott L, Lamb J, Smith S, Wheatley DN (2000) Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer 83:800\u2013810. https:\/\/doi.org\/10.1054\/bjoc.2000.1353","journal-title":"Br J Cancer"},{"key":"4335_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","volume":"36","author":"RB Caldwell","year":"2015","unstructured":"Caldwell RB, Toque HA, Narayanan SP, Caldwell RW (2015) Arginase: an old enzyme with new tricks. Trends Pharmacol Sci 36:395\u2013405. https:\/\/doi.org\/10.1016\/j.tips.2015.03.006","journal-title":"Trends Pharmacol Sci"},{"key":"4335_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopha.2018.02.109","volume":"102","author":"M Jahani","year":"2018","unstructured":"Jahani M, Noroznezhad F, Mansouri K (2018) Arginine: challenges and opportunities of this two-faced molecule in cancer therapy. Biomed Pharmacother 102:594\u2013601. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.109","journal-title":"Biomed Pharmacother"},{"key":"4335_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.oraloncology.2012.06.004","volume":"48","author":"CC Huang","year":"2012","unstructured":"Huang CC, Tsai ST, Kuo CC et al (2012) Arginine deprivation as a new treatment strategy for head and neck cancer. Oral Oncol 48:1227\u20131235. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.06.004","journal-title":"Oral Oncol"},{"key":"4335_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1042\/bj0240589","volume":"24","author":"E Gilroy","year":"1930","unstructured":"Gilroy E (1930) The influence of arginine upon the growth rate of a transplantable tumour in the mouse. Biochem J 24:589\u2013595","journal-title":"Biochem J"},{"key":"4335_CR11","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1038\/onc.2016.37","volume":"35","author":"MD Patil","year":"2016","unstructured":"Patil MD, Bhaumik J, Babykutty S et al (2016) Arginine dependence of tumor cells: targeting a chink in cancer\u2019s armor. Oncogene 35:4957\u20139724. https:\/\/doi.org\/10.1038\/onc.2016.37","journal-title":"Oncogene"},{"key":"4335_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s13762-018-1709-8","volume":"16","author":"KC dos Reis","year":"2019","unstructured":"dos Reis KC, Coimbra JM, Duarte WF et al (2019) Biological treatment of vinasse with yeast and simultaneous production of single-cell protein for feed supplementation. Int J Environ Sci Technol 16:763\u2013774. https:\/\/doi.org\/10.1007\/s13762-018-1709-8","journal-title":"Int J Environ Sci Technol"},{"key":"4335_CR13","first-page":"4522","volume":"50","author":"K Miyazaki","year":"1990","unstructured":"Miyazaki K, Takaku H, Umeda M et al (1990) Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 50:4522\u20134527","journal-title":"Cancer Res"},{"key":"4335_CR14","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1200\/jco.2005.23.16_suppl.4139","volume":"23","author":"KA Delman","year":"2005","unstructured":"Delman KA, Brown TD, Thomas M et al (2005) Phase I\/II trial of pegylated arginine deiminase (ADI-PEG20) in unresectable hepatocellular carcinoma. J Clin Oncol 23:4139\u20134139. https:\/\/doi.org\/10.1200\/jco.2005.23.16_suppl.4139","journal-title":"J Clin Oncol"},{"key":"4335_CR15","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1200\/jco.2006.24.18_suppl.8045","volume":"24","author":"LG Feun","year":"2006","unstructured":"Feun LG, Savaraj N, Marini A et al (2006) Phase II study of pegylated arginine deiminase (ADI-PEG20), a novel targeted therapy for melanoma. J Clin Oncol 24:8045\u20138045. https:\/\/doi.org\/10.1200\/jco.2006.24.18_suppl.8045","journal-title":"J Clin Oncol"},{"key":"4335_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10637-012-9862-2","volume":"31","author":"PA Ott","year":"2013","unstructured":"Ott PA, Carvajal RD, Pandit-Taskar N et al (2013) Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Invest New Drugs 31:425\u2013434. https:\/\/doi.org\/10.1007\/s10637-012-9862-2","journal-title":"Invest New Drugs"},{"key":"4335_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1196\/annals.1304.002","volume":"1009","author":"S Regunathan","year":"2003","unstructured":"Regunathan S, Piletz JE (2003) Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 1009:20\u201329. https:\/\/doi.org\/10.1196\/annals.1304.002","journal-title":"Ann N Y Acad Sci"},{"key":"4335_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"PN-M Cheng","year":"2007","unstructured":"Cheng PN-M, Lam T-L, Lam W-M et al (2007) Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67:309\u2013317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1945","journal-title":"Cancer Res"},{"key":"4335_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-5-17","volume":"5","author":"EC Hsueh","year":"2012","unstructured":"Hsueh EC, Knebel SM, Lo W-H et al (2012) Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol Oncol 5:17. https:\/\/doi.org\/10.1186\/1756-8722-5-17","journal-title":"J Hematol Oncol"},{"key":"4335_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1593\/tlo.10265","volume":"4","author":"ES Glazer","year":"2011","unstructured":"Glazer ES, Stone EM, Zhu C et al (2011) Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol 4:138\u2013146. https:\/\/doi.org\/10.1593\/tlo.10265","journal-title":"Transl Oncol"},{"key":"4335_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/CM9.0000000000001216","volume":"134","author":"JS Yang","year":"2021","unstructured":"Yang JS, Wang CC, Qiu JD et al (2021) Arginine metabolism: a potential target in pancreatic cancer therapy. Chin Med J 134:28\u201337. https:\/\/doi.org\/10.1097\/CM9.0000000000001216","journal-title":"Chin Med J"},{"key":"4335_CR22","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA et al (2010) Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood 115:5214\u20135221. https:\/\/doi.org\/10.1182\/blood-2009-12-258822","journal-title":"Blood"},{"key":"4335_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-014-1698-5","volume":"122","author":"O Khoury","year":"2015","unstructured":"Khoury O, Ghazale N, Stone E et al (2015) Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neuro-Oncol 122:75\u201385. https:\/\/doi.org\/10.1007\/s11060-014-1698-5","journal-title":"J Neuro-Oncol"},{"key":"4335_CR24","first-page":"3305","volume":"60","author":"R Singh","year":"2000","unstructured":"Singh R, Pervin S, Karimi A et al (2000) Arginase activity in human breast cancer cell lines: N\u03c9-Hydroxy-l-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 Cells. Cancer Res 60:3305\u20133312","journal-title":"Cancer Res"},{"key":"4335_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.359","volume":"4","author":"X Zeng","year":"2013","unstructured":"Zeng X, Li Y, Fan J et al (2013) Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin\u2019s lymphoma cells. Cell Death Dis 4:e840. https:\/\/doi.org\/10.1038\/cddis.2013.359","journal-title":"Cell Death Dis"},{"key":"4335_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1203\/PDR.0b013e3181fc6ab7","volume":"69","author":"C Tomlinson","year":"2011","unstructured":"Tomlinson C, Rafii M, Sgro M et al (2011) Arginine is synthesized from proline, not glutamate, in enterally fed human preterm neonates. Pediatr Res 69:46\u201350. https:\/\/doi.org\/10.1203\/PDR.0b013e3181fc6ab7","journal-title":"Pediatr Res"},{"key":"4335_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1159\/000495382","volume":"51","author":"C Riess","year":"2018","unstructured":"Riess C, Shokraie F, Classen CF et al (2018) Arginine-depleting enzymes\u2014an increasingly recognized treatment strategy for therapy-refractory malignancies. Cell Physiol Biochem 51:854\u2013870. https:\/\/doi.org\/10.1159\/000495382","journal-title":"Cell Physiol Biochem"},{"key":"4335_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/ijms17030363","volume":"17","author":"L Xiong","year":"2016","unstructured":"Xiong L, Teng JLL, Botelho MG et al (2016) Arginine metabolism in bacterial pathogenesis and cancer therapy. Int J Mol Sci 17:363. https:\/\/doi.org\/10.3390\/ijms17030363","journal-title":"Int J Mol Sci"},{"key":"4335_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.addr.2007.04.018","volume":"60","author":"G Pasut","year":"2008","unstructured":"Pasut G, Sergi M, Veronese FM (2008) Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev 60:69\u201378. https:\/\/doi.org\/10.1016\/j.addr.2007.04.018","journal-title":"Adv Drug Deliv Rev"},{"key":"4335_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0958-1669(03)00092-2","volume":"14","author":"M Vellard","year":"2003","unstructured":"Vellard M (2003) The enzyme as drug: application of enzymes as pharmaceuticals. Curr Opin Biotechnol 14:444\u2013450. https:\/\/doi.org\/10.1016\/S0958-1669(03)00092-2","journal-title":"Curr Opin Biotechnol"},{"key":"4335_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4155\/fmc.13.130","volume":"5","author":"MJ Lukey","year":"2013","unstructured":"Lukey MJ, Wilson KF, Cerione RA (2013) Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem 5:1685\u20131700. https:\/\/doi.org\/10.4155\/fmc.13.130","journal-title":"Future Med Chem"},{"key":"4335_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4155\/fmc-2016-0190","volume":"9","author":"WP Katt","year":"2017","unstructured":"Katt WP, Lukey MJ, Cerione RA (2017) A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis. Future Med Chem 9:223\u2013243. https:\/\/doi.org\/10.4155\/fmc-2016-0190","journal-title":"Future Med Chem"},{"key":"4335_CR33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1096\/fj.11-191254","volume":"26","author":"S Bansal","year":"2012","unstructured":"Bansal S, Srivastava A, Mukherjee G et al (2012) Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action. FASEB J 26:1161\u20131171. https:\/\/doi.org\/10.1096\/fj.11-191254","journal-title":"FASEB J"},{"key":"4335_CR34","unstructured":"Kundu B, Bansal S, Mishra P (2016) Mutants of L-asparaginase. Patent, US9322008B2"},{"key":"4335_CR35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1073\/pnas.71.4.1286","volume":"71","author":"AB Pardee","year":"1974","unstructured":"Pardee AB (1974) A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci 71:1286\u20131290. https:\/\/doi.org\/10.1073\/pnas.71.4.1286","journal-title":"Proc Natl Acad Sci"},{"key":"4335_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","volume":"28","author":"HJ M\u00fcller","year":"1998","unstructured":"M\u00fcller HJ, Boos J (1998) Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 28:97\u2013113. https:\/\/doi.org\/10.1016\/S1040-8428(98)00015-8","journal-title":"Crit Rev Oncol Hematol"},{"key":"4335_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tibs.2018.12.007","volume":"44","author":"P Icard","year":"2019","unstructured":"Icard P, Fournel L, Wu Z et al (2019) Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci 44:490\u2013521. https:\/\/doi.org\/10.1016\/j.tibs.2018.12.007","journal-title":"Trends Biochem Sci"},{"key":"4335_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.semcancer.2005.04.002","volume":"15","author":"DN Wheatley","year":"2005","unstructured":"Wheatley DN (2005) Arginine deprivation and metabolomics: Important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells. Semin Cancer Biol 15:247\u2013253. https:\/\/doi.org\/10.1016\/j.semcancer.2005.04.002","journal-title":"Semin Cancer Biol"},{"key":"4335_CR39","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","volume":"23","author":"PA Ascierto","year":"2005","unstructured":"Ascierto PA, Scala S, Castello G et al (2005) Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 23:7660\u20137668. https:\/\/doi.org\/10.1200\/JCO.2005.02.0933","journal-title":"J Clin Oncol"},{"key":"4335_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.83","volume":"3","author":"B Delage","year":"2012","unstructured":"Delage B, Luong P, Maharaj L et al (2012) Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis. Cell Death Dis 3:e342. https:\/\/doi.org\/10.1038\/cddis.2012.83","journal-title":"Cell Death Dis"},{"key":"4335_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2015.04.020","volume":"364","author":"F Qiu","year":"2015","unstructured":"Qiu F, Huang J, Sui M (2015) Targeting arginine metabolism pathway to treat arginine-dependent cancers. Cancer Lett 364:1\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.020","journal-title":"Cancer Lett"},{"key":"4335_CR42","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3892\/or.2015.4280","volume":"34","author":"H-L Huang","year":"2015","unstructured":"Huang H-L, Chen W-C, Hsu H-P et al (2015) Argininosuccinate lyase is a potential therapeutic target in breast cancer. Oncol Rep 34:3131\u20133139. https:\/\/doi.org\/10.3892\/or.2015.4280","journal-title":"Oncol Rep"},{"key":"4335_CR43","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3892\/or.2016.5334","volume":"37","author":"Y-H Hung","year":"2017","unstructured":"Hung Y-H, Huang H-L, Chen W-C et al (2017) Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells. Oncol Rep 37:969\u2013978. https:\/\/doi.org\/10.3892\/or.2016.5334","journal-title":"Oncol Rep"},{"key":"4335_CR44","doi-asserted-by":"publisher","first-page":"63506","DOI":"10.18632\/oncotarget.18843","volume":"8","author":"A Vardon","year":"2017","unstructured":"Vardon A, Dandapani M, Cheng D et al (2017) Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies. Oncotarget 8:63506\u201363517. https:\/\/doi.org\/10.18632\/oncotarget.18843","journal-title":"Oncotarget"},{"key":"4335_CR45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/138161208784246199","volume":"14","author":"L Feun","year":"2008","unstructured":"Feun L, You M, Wu CJ et al (2008) Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des 14:1049\u20131057. https:\/\/doi.org\/10.2174\/138161208784246199","journal-title":"Curr Pharm Des"},{"key":"4335_CR46","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/archsurg.1991.01410350066010","volume":"126","author":"TJ Yeatman","year":"1991","unstructured":"Yeatman TJ, Risley GL, Brunson ME (1991) Depletion of dietary arginine inhibits growth of metastatic tumor. Arch Surg 126:1376\u20131381. https:\/\/doi.org\/10.1001\/archsurg.1991.01410350066010 (Discussion 1381-1382)","journal-title":"Arch Surg"},{"key":"4335_CR47","first-page":"2932","volume":"51","author":"GG Gonzalez","year":"1991","unstructured":"Gonzalez GG, Byus CV (1991) Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse. Cancer Res 51:2932\u20132939","journal-title":"Cancer Res"},{"key":"4335_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jcb.23022","volume":"112","author":"SA Abdelmagid","year":"2011","unstructured":"Abdelmagid SA, Rickard JA, McDonald WJ et al (2011) CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines. J Cell Biochem 112:1084\u20131092. https:\/\/doi.org\/10.1002\/jcb.23022","journal-title":"J Cell Biochem"},{"key":"4335_CR49","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"12","author":"V Sosa","year":"2013","unstructured":"Sosa V, Molin\u00e9 T, Somoza R et al (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376\u2013390. https:\/\/doi.org\/10.1016\/j.arr.2012.10.004","journal-title":"Ageing Res Rev"},{"key":"4335_CR50","doi-asserted-by":"publisher","first-page":"14147","DOI":"10.1073\/pnas.1404171111","volume":"111","author":"CA Changou","year":"2014","unstructured":"Changou CA, Chen Y-R, Xing L et al (2014) Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci 111:14147\u201314152. https:\/\/doi.org\/10.1073\/pnas.1404171111","journal-title":"Proc Natl Acad Sci"},{"key":"4335_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41556-018-0042-2","volume":"20","author":"MD Rybstein","year":"2018","unstructured":"Rybstein MD, Pedro JMBS, Kroemer G, Galluzzi L (2018) The autophagic network and cancer. Nat Cell Biol 20:243\u2013251. https:\/\/doi.org\/10.1038\/s41556-018-0042-2","journal-title":"Nat Cell Biol"},{"key":"4335_CR52","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/ijc.25202","volume":"126","author":"B Delage","year":"2010","unstructured":"Delage B, Fennell DA, Nicholson L et al (2010) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126:2762\u20132772. https:\/\/doi.org\/10.1002\/ijc.25202","journal-title":"Int J Cancer"},{"key":"4335_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich S, Adler L, Yizhak K et al (2015) Diversion of aspartate in ASS1-deficient tumors fosters de novo pyrimidine synthesis. Nature 527:379\u2013383. https:\/\/doi.org\/10.1038\/nature15529","journal-title":"Nature"},{"key":"4335_CR54","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","volume":"69","author":"RH Kim","year":"2009","unstructured":"Kim RH, Coates JM, Bowles TL et al (2009) Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 69:700\u2013708. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3157","journal-title":"Cancer Res"},{"key":"4335_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41577-019-0140-9","volume":"19","author":"D O\u2019Sullivan","year":"2019","unstructured":"O\u2019Sullivan D, Sanin DE, Pearce EJ, Pearce EL (2019) Metabolic interventions in the immune response to cancer. Nat Rev Immunol 19:324\u2013335. https:\/\/doi.org\/10.1038\/s41577-019-0140-9","journal-title":"Nat Rev Immunol"},{"key":"4335_CR56","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/cncr.20407","volume":"101","author":"GJ Molderings","year":"2004","unstructured":"Molderings GJ, Kribben B, Heinen A et al (2004) Intestinal tumor and agmatine (decarboxylated arginine): low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro. Cancer 101:858\u2013868. https:\/\/doi.org\/10.1002\/cncr.20407","journal-title":"Cancer"},{"key":"4335_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbamcr.2004.12.004","volume":"1745","author":"C Mayeur","year":"2005","unstructured":"Mayeur C, Veuillet G, Michaud M et al (2005) Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle. Biochim Biophys Acta Mol Cell Res 1745:111\u2013123. https:\/\/doi.org\/10.1016\/j.bbamcr.2004.12.004","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4335_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1124\/mol.106.028449","volume":"71","author":"C Wolf","year":"2007","unstructured":"Wolf C, Br\u00fcss M, Hanisch B et al (2007) Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin. Mol Pharmacol 71:276\u2013283. https:\/\/doi.org\/10.1124\/mol.106.028449","journal-title":"Mol Pharmacol"},{"key":"4335_CR59","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.leukres.2010.12.023","volume":"35","author":"B Haenisch","year":"2011","unstructured":"Haenisch B, B\u00f6nisch H, Cichon S et al (2011) Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle. Leuk Res 35:1248\u20131253. https:\/\/doi.org\/10.1016\/j.leukres.2010.12.023","journal-title":"Leuk Res"},{"key":"4335_CR60","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/S0021-9258(17)40503-5","volume":"252","author":"JL Weickmann","year":"1977","unstructured":"Weickmann JL, Fahrney DE (1977) Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. J Biol Chem 252:2615\u20132620","journal-title":"J Biol Chem"},{"key":"4335_CR61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1128\/mr.50.3.314-352.1986","volume":"50","author":"R Cunin","year":"1986","unstructured":"Cunin R, Glansdorff N, Pi\u00e9rard A, Stalon V (1986) Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev 50:314\u2013352","journal-title":"Microbiol Rev"},{"key":"4335_CR62","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1462-2920.2008.01782.x","volume":"11","author":"S Ryan","year":"2009","unstructured":"Ryan S, Begley M, Gahan CGM, Hill C (2009) Molecular characterization of the arginine deiminase system in Listeria monocytogenes: regulation and role in acid tolerance. Environ Microbiol 11:432\u2013445. https:\/\/doi.org\/10.1111\/j.1462-2920.2008.01782.x","journal-title":"Environ Microbiol"},{"key":"4335_CR63","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/iai.68.5.2441-2448.2000","volume":"68","author":"D Ba","year":"2000","unstructured":"Ba D, Mc F, Ah D et al (2000) Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect Immun 68:2441\u20132448. https:\/\/doi.org\/10.1128\/iai.68.5.2441-2448.2000","journal-title":"Infect Immun"},{"key":"4335_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-14-42","volume":"14","author":"L Xiong","year":"2014","unstructured":"Xiong L, Teng JL, Watt RM et al (2014) Arginine deiminase pathway is far more important than urease for acid resistance and intracellular survival in Laribacter hongkongensis: a possible result of arc gene cassette duplication. BMC Microbiol 14:1\u201312. https:\/\/doi.org\/10.1186\/1471-2180-14-42","journal-title":"BMC Microbiol"},{"key":"4335_CR65","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1128\/IAI.00880-12","volume":"80","author":"Y Choi","year":"2012","unstructured":"Choi Y, Choi J, Groisman EA et al (2012) Expression of STM4467-encoded arginine deiminase controlled by the STM4463 regulator contributes to Salmonella enterica Serovar typhimurium virulence. Infect Immun 80:4291\u20134297. https:\/\/doi.org\/10.1128\/IAI.00880-12","journal-title":"Infect Immun"},{"key":"4335_CR66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ijc.2910510213","volume":"51","author":"H Takaku","year":"1992","unstructured":"Takaku H, Takase M, Abe S et al (1992) In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int J Cancer 51:244\u2013249. https:\/\/doi.org\/10.1002\/ijc.2910510213","journal-title":"Int J Cancer"},{"key":"4335_CR67","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1574-6968.2000.tb09344.x","volume":"191","author":"A Maghnouj","year":"2000","unstructured":"Maghnouj A, Abu-Bakr AAW, Baumberg S et al (2000) Regulation of anaerobic arginine catabolism in Bacillus licheniformis by a protein of the Crp\/Fnr family. FEMS Microbiol Lett 191:227\u2013234. https:\/\/doi.org\/10.1111\/j.1574-6968.2000.tb09344.x","journal-title":"FEMS Microbiol Lett"},{"key":"4335_CR68","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1128\/JB.180.16.4154-4159.1998","volume":"180","author":"M Z\u00fa\u00f1iga","year":"1998","unstructured":"Z\u00fa\u00f1iga M, Champomier-Verges M, Zagorec M, P\u00e9rez-Mart\u00ednez G (1998) Structural and functional analysis of the gene cluster encoding the enzymes of the arginine deiminase pathway of Lactobacillus sake. J Bacteriol 180:4154\u20134159","journal-title":"J Bacteriol"},{"key":"4335_CR69","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1128\/AEM.70.3.1321-1327.2004","volume":"70","author":"A Griswold","year":"2004","unstructured":"Griswold A, Chen Y-YM, Snyder JA, Burne RA (2004) Characterization of the arginine deiminase operon of Streptococcus rattus FA-1. Appl Environ Microbiol 70:1321\u20131327. https:\/\/doi.org\/10.1128\/AEM.70.3.1321-1327.2004","journal-title":"Appl Environ Microbiol"},{"key":"4335_CR70","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1128\/jb.173.15.4742-4750.1991","volume":"173","author":"M Gamper","year":"1991","unstructured":"Gamper M, Zimmermann A, Haas D (1991) Anaerobic regulation of transcription initiation in the arcDABC operon of Pseudomonas aeruginosa. J Bacteriol 173:4742\u20134750","journal-title":"J Bacteriol"},{"key":"4335_CR71","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/j.1349-7006.1993.tb02821.x","volume":"84","author":"H Takaku","year":"1993","unstructured":"Takaku H, Misawa S, Hayashi H, Miyazaki K (1993) Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini. Japn J Cancer Res 84:1195\u20131200. https:\/\/doi.org\/10.1111\/j.1349-7006.1993.tb02821.x","journal-title":"Japn J Cancer Res"},{"key":"4335_CR72","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1349-7006.1995.tb03094.x","volume":"86","author":"H Takaku","year":"1995","unstructured":"Takaku H, Matsumoto M, Misawa S, Miyazaki K (1995) Anti-tumor activity of arginine deiminase from mycoplasma arginini and its growth-inhibitory mechanism. Japn J Cancer Res 86:840\u2013846. https:\/\/doi.org\/10.1111\/j.1349-7006.1995.tb03094.x","journal-title":"Japn J Cancer Res"},{"key":"4335_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00008390-199209000-00007","volume":"2","author":"K Sugimura","year":"1992","unstructured":"Sugimura K, Ohno T, Kusuyama T, Azuma I (1992) High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro. Melanoma Res 2:191\u2013196. https:\/\/doi.org\/10.1097\/00008390-199209000-00007","journal-title":"Melanoma Res"},{"key":"4335_CR74","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/sj.leu.2401763","volume":"14","author":"H Gong","year":"2000","unstructured":"Gong H, Z\u00f6lzer F, von Recklinghausen G et al (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14:826\u2013829. https:\/\/doi.org\/10.1038\/sj.leu.2401763","journal-title":"Leukemia"},{"key":"4335_CR75","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/bjc.2011.524","volume":"106","author":"MP Kelly","year":"2012","unstructured":"Kelly MP, Jungbluth AA, Wu B-W et al (2012) Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. Br J Cancer 106:324\u2013332. https:\/\/doi.org\/10.1038\/bjc.2011.524","journal-title":"Br J Cancer"},{"key":"4335_CR76","first-page":"5443","volume":"62","author":"CM Ensor","year":"2002","unstructured":"Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA (2002) Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res 62:5443\u20135450","journal-title":"Cancer Res"},{"key":"4335_CR77","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0168-3659(02)00042-1","volume":"80","author":"FW Holtsberg","year":"2002","unstructured":"Holtsberg FW, Ensor CM, Steiner MR et al (2002) Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. J Control Release 80:259\u2013271. https:\/\/doi.org\/10.1016\/S0168-3659(02)00042-1","journal-title":"J Control Release"},{"key":"4335_CR78","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/ijms18061175","volume":"18","author":"A Thongkum","year":"2017","unstructured":"Thongkum A, Wu C, Li Y-Y et al (2017) The combination of arginine deprivation and 5-fluorouracil improves therapeutic efficacy in argininosuccinate synthetase negative hepatocellular carcinoma. Int J Mol Sci 18:1175. https:\/\/doi.org\/10.3390\/ijms18061175","journal-title":"Int J Mol Sci"},{"key":"4335_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-686","volume":"14","author":"J Liu","year":"2014","unstructured":"Liu J, Ma J, Wu Z et al (2014) Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-\u03baB signaling. BMC Cancer 14:1\u201317. https:\/\/doi.org\/10.1186\/1471-2407-14-686","journal-title":"BMC Cancer"},{"key":"4335_CR80","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.18632\/oncotarget.3370","volume":"6","author":"N Savaraj","year":"2015","unstructured":"Savaraj N, Wu C, Li Y-Y et al (2015) Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget 6:6295\u20136309. https:\/\/doi.org\/10.18632\/oncotarget.3370","journal-title":"Oncotarget"},{"key":"4335_CR81","unstructured":"Jones JB (1981) The effect of arginine deiminase on murine leukemic lymphoblasts. PhD Thesis, University of Oklahoma Health Sciences Center"},{"key":"4335_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0168-1656(94)90050-7","volume":"36","author":"S Misawa","year":"1994","unstructured":"Misawa S, Aoshima M, Takaku H et al (1994) High-level expression of mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J Biotechnol 36:145\u2013155. https:\/\/doi.org\/10.1016\/0168-1656(94)90050-7","journal-title":"J Biotechnol"},{"key":"4335_CR83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/bbrc.1999.1004","volume":"261","author":"H Gong","year":"1999","unstructured":"Gong H, Z\u00f6lzer F, von Recklinghausen G et al (1999) Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun 261:10\u201314. https:\/\/doi.org\/10.1006\/bbrc.1999.1004","journal-title":"Biochem Biophys Res Commun"},{"key":"4335_CR84","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3835(01)00793-5","volume":"183","author":"K Beloussow","year":"2002","unstructured":"Beloussow K, Wang L, Wu J et al (2002) Recombinant arginine deiminase as a potential anti-angiogenic agent. Cancer Lett 183:155\u2013162. https:\/\/doi.org\/10.1016\/S0304-3835(01)00793-5","journal-title":"Cancer Lett"},{"key":"4335_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S030-43835(02)00693-6","volume":"191","author":"L-J Shen","year":"2003","unstructured":"Shen L-J, Lin W-C, Beloussow K, Shen W-C (2003) Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett 191:165\u2013170. https:\/\/doi.org\/10.1016\/S030-43835(02)00693-6","journal-title":"Cancer Lett"},{"key":"4335_CR86","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.20435","volume":"112","author":"E-J Noh","year":"2004","unstructured":"Noh E-J, Kang S-W, Shin Y-J et al (2004) Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells. Int J Cancer 112:502\u2013508. https:\/\/doi.org\/10.1002\/ijc.20435","journal-title":"Int J Cancer"},{"key":"4335_CR87","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.22322","volume":"120","author":"C-Y Yoon","year":"2007","unstructured":"Yoon C-Y, Shim Y-J, Kim E-H et al (2007) Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer 120:897\u2013905. https:\/\/doi.org\/10.1002\/ijc.22322","journal-title":"Int J Cancer"},{"key":"4335_CR88","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/ijc.23723","volume":"123","author":"TL Bowles","year":"2008","unstructured":"Bowles TL, Kim R, Galante J et al (2008) Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer 123:1950\u20131955. https:\/\/doi.org\/10.1002\/ijc.23723","journal-title":"Int J Cancer"},{"key":"4335_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/1538-7445.AM10-61","volume":"70","author":"M You","year":"2010","unstructured":"You M, Savaraj N, Wu C et al (2010) Abstract 61: enhancing arginine deprivation therapy in melanoma by combining with cisplatin. Cancer Res 70:61\u201361. https:\/\/doi.org\/10.1158\/1538-7445.AM10-61","journal-title":"Cancer Res"},{"key":"4335_CR90","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","volume":"22","author":"F Izzo","year":"2004","unstructured":"Izzo F, Marra P, Beneduce G et al (2004) Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies. J Clin Oncol 22:1815\u20131822. https:\/\/doi.org\/10.1200\/JCO.2004.11.120","journal-title":"J Clin Oncol"},{"key":"4335_CR91","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/sj.bjc.6605856","volume":"103","author":"TS Yang","year":"2010","unstructured":"Yang TS, Lu SN, Chao Y et al (2010) A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer 103:954\u2013960. https:\/\/doi.org\/10.1038\/sj.bjc.6605856","journal-title":"Br J Cancer"},{"key":"4335_CR92","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1002\/cncr.30897","volume":"123","author":"MA Lowery","year":"2017","unstructured":"Lowery MA, Yu KH, Kelsen DP et al (2017) A phase 1\/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Cancer 123:4556\u20134565. https:\/\/doi.org\/10.1002\/cncr.30897","journal-title":"Cancer"},{"key":"4335_CR93","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1200\/JCO.2016.71.3230","volume":"35","author":"E Beddowes","year":"2017","unstructured":"Beddowes E, Spicer J, Chan PY et al (2017) Phase 1 Dose-escalation study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1\u2013deficient thoracic cancers. J Clin Oncol 35:1778\u20131785. https:\/\/doi.org\/10.1200\/JCO.2016.71.3230","journal-title":"J Clin Oncol"},{"key":"4335_CR94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaoncol.2016.3049","volume":"3","author":"PW Szlosarek","year":"2017","unstructured":"Szlosarek PW, Steele JP, Nolan L et al (2017) Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1-deficient malignant pleural mesothelioma: a randomized clinical trial. JAMA Oncol 3:58\u201366. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3049","journal-title":"JAMA Oncol"},{"key":"4335_CR95","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00280-018-3635-3","volume":"82","author":"JJ Harding","year":"2018","unstructured":"Harding JJ, Do RK, Dika IE et al (2018) A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies. Cancer Chemother Pharmacol 82:429\u2013440. https:\/\/doi.org\/10.1007\/s00280-018-3635-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"4335_CR96","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/1078-0432","volume":"25","author":"PE Hall","year":"2019","unstructured":"Hall PE, Lewis R, Syed N et al (2019) A Phase I study of pegylated arginine deiminase (pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma. Clin Cancer Res 25:2708\u20132716. https:\/\/doi.org\/10.1158\/1078-0432","journal-title":"Clin Cancer Res"},{"key":"4335_CR97","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1002\/cam4.3871","volume":"10","author":"HJ Tsai","year":"2021","unstructured":"Tsai HJ, Hsiao HH, Hsu YT et al (2021) Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia. Cancer Med 10:2946\u20132955. https:\/\/doi.org\/10.1002\/cam4.3871","journal-title":"Cancer Med"},{"key":"4335_CR98","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41416-020-01230-8","volume":"124","author":"S Yao","year":"2021","unstructured":"Yao S, Janku F, Subbiah V et al (2021) Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies. Br J Cancer 124:1533\u20131539. https:\/\/doi.org\/10.1038\/s41416-020-01230-8","journal-title":"Br J Cancer"},{"key":"4335_CR99","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0014-5793(96)00459-0","volume":"386","author":"MC Bewley","year":"1996","unstructured":"Bewley MC, Lott JS, Baker EN, Patchett ML (1996) The cloning, expression and crystallisation of a thermostable arginase. FEBS Lett 386:215\u2013218. https:\/\/doi.org\/10.1016\/0014-5793(96)00459-0","journal-title":"FEBS Lett"},{"key":"4335_CR100","first-page":"109","volume":"19","author":"G Muszynska","year":"1972","unstructured":"Muszynska G, Severina LO, Lobyreva LW (1972) Characteristics of arginases from plant, ureotelic and uricotelic organisms. Acta Biochim Pol 19:109\u2013116","journal-title":"Acta Biochim Pol"},{"key":"4335_CR101","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-291X(86)80333-3","volume":"141","author":"GJ Dizikes","year":"1986","unstructured":"Dizikes GJ, Grody WW, Kern RM, Cederbaum SD (1986) Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes. Biochem Biophys Res Commun 141:53\u201359. https:\/\/doi.org\/10.1016\/S0006-291X(86)80333-3","journal-title":"Biochem Biophys Res Commun"},{"key":"4335_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0014-5793(96)01015-0","volume":"395","author":"T Gotoh","year":"1996","unstructured":"Gotoh T, Sonoki T, Nagasaki A et al (1996) Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett 395:119\u2013122. https:\/\/doi.org\/10.1016\/0014-5793(96)01015-0","journal-title":"FEBS Lett"},{"key":"4335_CR103","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/geno.1996.0606","volume":"38","author":"JG Vockley","year":"1996","unstructured":"Vockley JG, Jenkinson CP, Shukla H et al (1996) Cloning and characterization of the human type II arginase gene. Genomics 38:118\u2013123. https:\/\/doi.org\/10.1006\/geno.1996.0606","journal-title":"Genomics"},{"key":"4335_CR104","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1021\/bi0491705","volume":"43","author":"E Cama","year":"2004","unstructured":"Cama E, Pethe S, Boucher J-L et al (2004) Inhibitor coordination interactions in the binuclear manganese cluster of arginase I. Biochemistry 43:8987\u20138999. https:\/\/doi.org\/10.1021\/bi0491705","journal-title":"Biochemistry"},{"key":"4335_CR105","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1476-5381.2009.00278.x","volume":"157","author":"SM Morris","year":"2009","unstructured":"Morris SM (2009) Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 157:922\u2013930. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00278.x","journal-title":"Br J Pharmacol"},{"key":"4335_CR106","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fimmu.2014.00544","volume":"5","author":"JM Dzik","year":"2014","unstructured":"Dzik JM (2014) Evolutionary roots of arginase expression and regulation. Front Immunol 5:544. https:\/\/doi.org\/10.3389\/fimmu.2014.00544","journal-title":"Front Immunol"},{"key":"4335_CR107","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1078\/0171-9335-00384","volume":"83","author":"ME Legaz","year":"2004","unstructured":"Legaz ME, Fontaniella B, Millanes AM, Vicente C (2004) Secreted arginases from phylogenetically far-related lichen species act as cross-recognition factors for two different algal cells. Eur J Cell Biol 83:435\u2013446. https:\/\/doi.org\/10.1078\/0171-9335-00384","journal-title":"Eur J Cell Biol"},{"key":"4335_CR108","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/ppa.12537","volume":"65","author":"M Labudda","year":"2016","unstructured":"Labudda M, R\u00f3\u017ca\u0144ska E, Cie\u015bla J et al (2016) Arginase activity in Arabidopsis thaliana infected with Heterodera schachtii. Plant Pathol 65:1529\u20131538. https:\/\/doi.org\/10.1111\/ppa.12537","journal-title":"Plant Pathol"},{"key":"4335_CR109","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jxb\/ers400","volume":"64","author":"H Shi","year":"2013","unstructured":"Shi H, Ye T, Chen F et al (2013) Manipulation of arginase expression modulates abiotic stress tolerance in Arabidopsis: effect on arginine metabolism and ROS accumulation. J Exp Bot 64:1367\u20131379. https:\/\/doi.org\/10.1093\/jxb\/ers400","journal-title":"J Exp Bot"},{"key":"4335_CR110","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00425-001-0720-2","volume":"215","author":"CD Todd","year":"2002","unstructured":"Todd CD, Gifford DJ (2002) The role of the megagametophyte in maintaining loblolly pine (Pinus taeda L.) seedling arginase gene expression in vitro. Planta 215:110\u2013118. https:\/\/doi.org\/10.1007\/s00425-001-0720-2","journal-title":"Planta"},{"key":"4335_CR111","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2672.2003.02132.x","volume":"96","author":"G Spano","year":"2004","unstructured":"Spano G, Chieppa G, Beneduce L, Massa S (2004) Expression analysis of putative arcA, arcB and arcC genes partially cloned from Lactobacillus plantarum isolated from wine. J Appl Microbiol 96:185\u2013193. https:\/\/doi.org\/10.1046\/j.1365-2672.2003.02132.x","journal-title":"J Appl Microbiol"},{"key":"4335_CR112","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0168-1605(99)00133-6","volume":"52","author":"ME Arena","year":"1999","unstructured":"Arena ME, Saguir FM, Manca de Nadra MC (1999) Arginine, citrulline and ornithine metabolism by lactic acid bacteria from wine. Int J Food Microbiol 52:155\u2013161. https:\/\/doi.org\/10.1016\/S0168-1605(99)00133-6","journal-title":"Int J Food Microbiol"},{"key":"4335_CR113","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12275-010-0204-9","volume":"48","author":"JJ Yu","year":"2010","unstructured":"Yu JJ, Oh SH (2010) Isolation and characterization of lactic acid bacteria strains with ornithine producing capacity from natural sea salt. J Microbiol 48:467\u2013472. https:\/\/doi.org\/10.1007\/s12275-010-0204-9","journal-title":"J Microbiol"},{"key":"4335_CR114","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1017\/S0007114509990432","volume":"102","author":"JE Kim","year":"2009","unstructured":"Kim JE, Kim SY, Lee KW, Lee HJ (2009) Arginine deiminase originating from Lactococcus lactis ssp. lactis American Type Culture Collection (ATCC) 7962 induces G1-phase cell-cycle arrest and apoptosis in SNU-1 stomach adenocarcinoma cells. Br J Nutr 102:1469\u20131476. https:\/\/doi.org\/10.1017\/S0007114509990432","journal-title":"Br J Nutr"},{"key":"4335_CR115","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1128\/JB.181.23.7314-7322.1999","volume":"181","author":"DJ McGee","year":"1999","unstructured":"McGee DJ, Radcliff FJ, Mendz GL et al (1999) Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol 181:7314\u20137322. https:\/\/doi.org\/10.1128\/JB.181.23.7314-7322.1999","journal-title":"J Bacteriol"},{"key":"4335_CR116","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0167-4838(91)90543-9","volume":"1077","author":"ML Patchett","year":"1991","unstructured":"Patchett ML, Daniel RM, Morgan HW (1991) Characterisation of arginase from the extreme thermophile \u2018Bacillus caldovelox\u2019. Biochim Biophys Acta Protein Struct Mol Enzymol 1077:291\u2013298. https:\/\/doi.org\/10.1016\/0167-4838(91)90543-9","journal-title":"Biochim Biophys Acta Protein Struct Mol Enzymol"},{"key":"4335_CR117","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/adsc.201000034","volume":"352","author":"PM K\u00f6nst","year":"2010","unstructured":"K\u00f6nst PM, Turras PMCCD, Franssen MCR et al (2010) Stabilized and immobilized Bacillus subtilis arginase for the biobased production of nitrogen-containing chemicals. Adv Synth Catal 352:1493\u20131502. https:\/\/doi.org\/10.1002\/adsc.201000034","journal-title":"Adv Synth Catal"},{"key":"4335_CR118","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1080\/00021369.1973.10861080","volume":"37","author":"N Nakamura","year":"1973","unstructured":"Nakamura N, Fujita M, Kimura K (1973) Purification and properties of L-arginase from Bacillus subtilis. Agric Biol Chem 37:2827\u20132833. https:\/\/doi.org\/10.1080\/00021369.1973.10861080","journal-title":"Agric Biol Chem"},{"key":"4335_CR119","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1271\/bbb.58.1045","volume":"58","author":"KW Shimotohno","year":"1994","unstructured":"Shimotohno KW, Iida J, Takizawa N, Endo T (1994) Purification and characterization of arginine amidinohydrolase from Bacillus brevis TT02-8. Biosci Biotechnol Biochem 58:1045\u20131049. https:\/\/doi.org\/10.1271\/bbb.58.1045","journal-title":"Biosci Biotechnol Biochem"},{"key":"4335_CR120","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/abbi.1997.0174","volume":"344","author":"M Kanda","year":"1997","unstructured":"Kanda M, Ohgishi K, Hanawa T, Saito Y (1997) Arginase of Bacillus brevis Nagano: purification, properties, and implication in gramicidin s biosynthesis. Arch Biochem Biophys 344:37\u201342. https:\/\/doi.org\/10.1006\/abbi.1997.0174","journal-title":"Arch Biochem Biophys"},{"key":"4335_CR121","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12275-013-2669-9","volume":"51","author":"JJ Yu","year":"2013","unstructured":"Yu JJ, Park KB, Kim SG, Oh SH (2013) Expression, purification, and biochemical properties of arginase from Bacillus subtilis 168. J Microbiol 51:222\u2013228. https:\/\/doi.org\/10.1007\/s12275-013-2669-9","journal-title":"J Microbiol"},{"key":"4335_CR122","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcatb.2016.11.020","volume":"133","author":"K Huang","year":"2016","unstructured":"Huang K, Zhang T, Jiang B et al (2016) Characterization of a thermostable arginase from Rummeliibacillus pycnus SK31.001. J Mol Catal B: Enzym 133:68\u201375. https:\/\/doi.org\/10.1016\/j.molcatb.2016.11.020","journal-title":"J Mol Catal B: Enzym"},{"key":"4335_CR123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cbi.2017.07.001","volume":"274","author":"I Husain","year":"2017","unstructured":"Husain I, Bala K, Wani A et al (2017) Arginase purified from endophytic Pseudomonas aeruginosa IH2: induce apoptosis through both cell cycle arrest and MMP loss in human leukemic HL-60 cells. Chem Biol Interact 274:35\u201349. https:\/\/doi.org\/10.1016\/j.cbi.2017.07.001","journal-title":"Chem Biol Interact"},{"key":"4335_CR124","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1016\/S0021-9258(18)48206-3","volume":"262","author":"KA Borkovich","year":"1987","unstructured":"Borkovich KA, Weiss RL (1987) Purification and characterization of arginase from Neurospora crassa. J Biol Chem 262:7081\u20137086","journal-title":"J Biol Chem"},{"key":"4335_CR125","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-014-0498-y","author":"AS El-Sayed","year":"2014","unstructured":"El-Sayed AS, Shindia AA, Diab AA, Rady AM (2014) Purification and immobilization of l-arginase from thermotolerant Penicillium chrysogenum KJ185377.1; with unique kinetic properties as thermostable anticancer enzyme. Arch Pharm Res. https:\/\/doi.org\/10.1007\/s12272-014-0498-y","journal-title":"Arch Pharm Res"},{"key":"4335_CR126","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s1087-1845(02)00522-4","volume":"38","author":"A Dzikowska","year":"2003","unstructured":"Dzikowska A, Kacprzak M, Tomecki R et al (2003) Specific induction and carbon\/nitrogen repression of arginine catabolism gene of Aspergillus nidulans\u2013functional in vivo analysis of the otaA promoter. Fungal Genet Biol 38:175\u2013186. https:\/\/doi.org\/10.1016\/s1087-1845(02)00522-4","journal-title":"Fungal Genet Biol"},{"key":"4335_CR127","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0021-9258(19)40059-8","volume":"265","author":"SM Green","year":"1990","unstructured":"Green SM, Eisenstein E, McPhie P, Hensley P (1990) The purification and characterization of arginase from Saccharomyces cerevisiae. J Biol Chem 265:1601\u20131607","journal-title":"J Biol Chem"},{"key":"4335_CR128","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.lwt.2017.04.044","volume":"82","author":"I Benucci","year":"2017","unstructured":"Benucci I, Fiorelli V, Lombardelli C et al (2017) Kinetic characterization of arginase from Saccharomyces cerevisiae during alcoholic fermentation at different temperatures. LWT-Food Sci Technol 82:268\u2013273. https:\/\/doi.org\/10.1016\/j.lwt.2017.04.044","journal-title":"LWT-Food Sci Technol"},{"key":"4335_CR129","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/mmi.12666","volume":"93","author":"G Romagnoli","year":"2014","unstructured":"Romagnoli G, Verhoeven MD, Mans R et al (2014) An alternative, arginase-independent pathway for arginine metabolism in Kluyveromyces lactis involves guanidinobutyrase as a key enzyme. Mol Microbiol 93:369\u2013389. https:\/\/doi.org\/10.1111\/mmi.12666","journal-title":"Mol Microbiol"},{"key":"4335_CR130","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3109\/15419069809010796","volume":"6","author":"MC Molina","year":"1998","unstructured":"Molina MC, Stocker-W\u00f6rg\u00f6tter E, Turk R et al (1998) Secreted, glycosylated arginase from Xanthoria parietina thallus induces loss of cytoplasmic material from Xanthoria photobionts. Cell Adhes Commun 6:481\u2013490. https:\/\/doi.org\/10.3109\/15419069809010796","journal-title":"Cell Adhes Commun"},{"key":"4335_CR131","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4161\/psb.4.7.9164","volume":"4","author":"E-M D\u00edaz","year":"2009","unstructured":"D\u00edaz E-M, Sacrist\u00e1n M, Legaz M-E, Vicente C (2009) Isolation and characterization of a cyanobacterium-binding protein and its cell wall receptor in the lichen Peltigera canina. Plant Signal Behav 4:598\u2013603. https:\/\/doi.org\/10.4161\/psb.4.7.9164","journal-title":"Plant Signal Behav"},{"key":"4335_CR132","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1432-1033.1982.tb06861.x","volume":"127","author":"J-P Boutin","year":"1982","unstructured":"Boutin J-P (1982) Purification, Properties and subunit structure of arginase from iris bulbs. Eur J Biochem 127:237\u2013243. https:\/\/doi.org\/10.1111\/j.1432-1033.1982.tb06861.x","journal-title":"Eur J Biochem"},{"key":"4335_CR133","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0031-9422(01)00392-2","volume":"58","author":"HJ Hwang","year":"2001","unstructured":"Hwang HJ, Kim EH, Cho YD (2001) Isolation and properties of arginase from a shade plant, ginseng (Panax ginseng C.A. Meyer) roots. Phytochemistry 58:1015\u20131024. https:\/\/doi.org\/10.1016\/S0031-9422(01)00392-2","journal-title":"Phytochemistry"},{"key":"4335_CR134","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0031-9422(73)80678-8","volume":"12","author":"WE Splittstoesser","year":"1973","unstructured":"Splittstoesser WE, Fowden L (1973) Ornithine transaminase from Cucurbita maxima cotyledons. Phytochemistry 12:785\u2013790. https:\/\/doi.org\/10.1016\/0031-9422(73)80678-8","journal-title":"Phytochemistry"},{"key":"4335_CR135","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1104\/pp.55.3.507","volume":"55","author":"C Koll\u00f6ffel","year":"1975","unstructured":"Koll\u00f6ffel C, van Dijke HD (1975) Mitochondrial arginase activity from cotyledons of developing and germinating seeds of Vicia faba L. Plant Physiol 55:507\u2013510. https:\/\/doi.org\/10.1104\/pp.55.3.507","journal-title":"Plant Physiol"},{"key":"4335_CR136","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1104\/pp.107.4.1097","volume":"107","author":"LE Zonia","year":"1995","unstructured":"Zonia LE, Stebbins NE, Polacco JC (1995) Essential role of urease in germination of nitrogen-limited Arabidopsis thaliana seeds. Plant Physiol 107:1097\u20131103. https:\/\/doi.org\/10.1104\/pp.107.4.1097","journal-title":"Plant Physiol"},{"key":"4335_CR137","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1104\/pp.112.3.1237","volume":"112","author":"D Alabadi","year":"1996","unstructured":"Alabadi D, Aguero MS, Perez-Amador MA, Carbonell J (1996) Arginase, arginine decarboxylase, ornithine decarboxylase, and polyamines in tomato ovaries (changes in unpollinated ovaries and parthenocarpic fruits induced by auxin or gibberellin). Plant Physiol 112:1237\u20131244. https:\/\/doi.org\/10.1104\/pp.112.3.1237","journal-title":"Plant Physiol"},{"key":"4335_CR138","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1104\/pp.73.4.965","volume":"73","author":"KR Downum","year":"1983","unstructured":"Downum KR, Rosenthal GA, Cohen WS (1983) l-Arginine and l-canavanine metabolism in jack bean, Canavalia ensiformis (L.) DC. and SOYBEAN, Glycine max (L.) Merr. Plant Physiol 73:965\u2013968. https:\/\/doi.org\/10.1104\/pp.73.4.965","journal-title":"Plant Physiol"},{"key":"4335_CR139","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1104\/pp.119.1.297","volume":"119","author":"A Goldraij","year":"1999","unstructured":"Goldraij A, Polacco JC (1999) Arginase is inoperative in developing soybean embryos. Plant Physiol 119:297. https:\/\/doi.org\/10.1104\/pp.119.1.297","journal-title":"Plant Physiol"},{"issue":"4","key":"4335_CR140","first-page":"236","volume":"20","author":"HV Desai","year":"1983","unstructured":"Desai HV (1983) Purification and properties of arginase from Arachis hypogea L. seedlings. Indian J Biochem Biophys 20(4):236\u2013237","journal-title":"Indian J Biochem Biophys"},{"key":"4335_CR141","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ijbiomac.2018.06.096","volume":"118","author":"S Siddappa","year":"2018","unstructured":"Siddappa S, Basrur V, Ravishankar Rai V, Marathe GK (2018) Biochemical and functional characterization of an atypical plant l-arginase from Cilantro (Coriandrum sativam L.). Int J Biol Macromol 118:844\u2013856. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.06.096","journal-title":"Int J Biol Macromol"},{"key":"4335_CR142","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1042\/bj0890263","volume":"89","author":"SJ Bach","year":"1963","unstructured":"Bach SJ, Hawkins RA, Swaine D (1963) A short method for the purification of arginase from ox liver. Biochem J 89:263\u2013265","journal-title":"Biochem J"},{"key":"4335_CR143","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/bjc.1965.45","volume":"19","author":"SJ Bach","year":"1965","unstructured":"Bach SJ, Swaine D (1965) The effect of arginase on the retardation of tumour growth. Br J Cancer 19:379\u2013386","journal-title":"Br J Cancer"},{"key":"4335_CR144","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0005-2795(79)90111-9","volume":"578","author":"KV Savoca","year":"1979","unstructured":"Savoca KV, Abuchowski A, van Es T et al (1979) Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol. Biochim Biophys Acta 578:47\u201353. https:\/\/doi.org\/10.1016\/0005-2795(79)90111-9","journal-title":"Biochim Biophys Acta"},{"key":"4335_CR145","first-page":"261","volume":"7","author":"KV Savoca","year":"1984","unstructured":"Savoca KV, Davis FF, Van TE et al (1984) Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia. Cancer Biochem Biophys 7:261\u2013268","journal-title":"Cancer Biochem Biophys"},{"key":"4335_CR146","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/cb900267j","volume":"5","author":"EM Stone","year":"2010","unstructured":"Stone EM, Glazer ES, Chantranupong L et al (2010) Replacing Mn2+ with Co2+ in human arginase I enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines. ACS Chem Biol 5:333\u2013342. https:\/\/doi.org\/10.1021\/cb900267j","journal-title":"ACS Chem Biol"},{"key":"4335_CR147","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.leukres.2013.08.007","volume":"37","author":"R Tanios","year":"2013","unstructured":"Tanios R, Bekdash A, Kassab E et al (2013) Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res 37:1565\u20131571. https:\/\/doi.org\/10.1016\/j.leukres.2013.08.007","journal-title":"Leuk Res"},{"key":"4335_CR148","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/CPAA.S37350","volume":"5","author":"J-K Yoon","year":"2012","unstructured":"Yoon J-K, Frankel AE, Feun LG et al (2012) Arginine deprivation therapy for malignant melanoma. Clin Pharmacol 5:11\u201319. https:\/\/doi.org\/10.2147\/CPAA.S37350","journal-title":"Clin Pharmacol"},{"key":"4335_CR149","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.clindermatol.2012.08.016","volume":"31","author":"JJ Luke","year":"2013","unstructured":"Luke JJ, Schwartz GK (2013) Chemotherapy in the management of advanced cutaneous malignant melanoma. Clin Dermatol 31:290\u2013297. https:\/\/doi.org\/10.1016\/j.clindermatol.2012.08.016","journal-title":"Clin Dermatol"},{"key":"4335_CR150","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00042737-200505000-00002","volume":"17","author":"D Moradpour","year":"2005","unstructured":"Moradpour D, Blum HE (2005) Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17:477. https:\/\/doi.org\/10.1097\/00042737-200505000-00002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4335_CR151","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.3748\/wjg.v11.i47.7391","volume":"11","author":"HE Blum","year":"2005","unstructured":"Blum HE (2005) Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 11:7391\u20137400. https:\/\/doi.org\/10.3748\/wjg.v11.i47.7391","journal-title":"World J Gastroenterol"},{"key":"4335_CR152","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbrc.2008.09.093","volume":"377","author":"A Chrzanowska","year":"2008","unstructured":"Chrzanowska A, Krawczyk M, Baranczyk-Kuzma A (2008) Changes in arginase isoenzymes pattern in human hepatocellular carcinoma. Biochem Biophys Res Commun 377:337\u2013340. https:\/\/doi.org\/10.1016\/j.bbrc.2008.09.093","journal-title":"Biochem Biophys Res Commun"},{"key":"4335_CR153","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/jco.2005.23.16_suppl.3179","volume":"23","author":"PN Cheng","year":"2005","unstructured":"Cheng PN, Lo TWH, Leung TWH et al (2005) Pegylated recombinant human arginase (rhArg-peg 5000mw) has in vitro and in vivo anti-proliferative potential and apoptotic activities in human hepatocellular varcinoma (HCC). J Clin Oncol 23:3179\u20133179. https:\/\/doi.org\/10.1200\/jco.2005.23.16_suppl.3179","journal-title":"J Clin Oncol"},{"key":"4335_CR154","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2867-9-9","volume":"9","author":"SM Tsui","year":"2009","unstructured":"Tsui SM, Lam WM, Lam TL et al (2009) Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC). Cancer Cell Int 9:1-13. https:\/\/doi.org\/10.1186\/1475-2867-9-9","journal-title":"Cancer Cell Int"},{"key":"4335_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109210","volume":"118","author":"S Zou","year":"2019","unstructured":"Zou S, Wang X, Liu P et al (2019) Arginine metabolism and deprivation in cancer therapy. Biomed Pharmacother 118:109210. https:\/\/doi.org\/10.1016\/j.biopha.2019.109210","journal-title":"Biomed Pharmacother"},{"key":"4335_CR156","doi-asserted-by":"publisher","first-page":"8399","DOI":"10.1021\/bi301145n","volume":"51","author":"EL D\u2019Antonio","year":"2012","unstructured":"D\u2019Antonio EL, Hai Y, Christianson DW (2012) Structure and function of non-native metal clusters in human arginase I. Biochemistry 51:8399\u20138409. https:\/\/doi.org\/10.1021\/bi301145n","journal-title":"Biochemistry"},{"key":"4335_CR157","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA et al (2018) Arginase: a multifaceted enzyme important in health and disease. Physiol Rev 98:641\u2013665. https:\/\/doi.org\/10.1152\/physrev.00037.2016","journal-title":"Physiol Rev"},{"key":"4335_CR158","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/bjc.1974.112","volume":"30","author":"JM Storr","year":"1974","unstructured":"Storr JM, Burton AF (1974) The effects of arginine deficiency on lymphoma cells. Br J Cancer 30:50. https:\/\/doi.org\/10.1038\/bjc.1974.112","journal-title":"Br J Cancer"},{"key":"4335_CR159","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3181\/00379727-149-38923","volume":"149","author":"JA Nelson","year":"1975","unstructured":"Nelson JA, Carpenter JW, Morris HP (1975) Growth inhibitory and arginase activities in liver and hepatoma extracts. Proc Soc Expl Biol Med 149:900\u2013902. https:\/\/doi.org\/10.3181\/00379727-149-38923","journal-title":"Proc Soc Expl Biol Med"},{"key":"4335_CR160","unstructured":"Cheng N, Leung Y, Lo W (2005) Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation. Patent, EP1908478B1"},{"key":"4335_CR161","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2008.11.031","volume":"277","author":"TL Lam","year":"2009","unstructured":"Lam TL, Wong GKY, Chong HC et al (2009) Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest. Cancer Lett 277:91\u2013100. https:\/\/doi.org\/10.1016\/j.canlet.2008.11.031","journal-title":"Cancer Lett"},{"key":"4335_CR162","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/CJI.0b013e3181cd8746","volume":"33","author":"JI Ellyard","year":"2010","unstructured":"Ellyard JI, Quah BJC, Simson L, Parish CR (2010) Alternatively activated macrophage possess antitumor cytotoxicity that is induced by IL-4 and mediated by arginase-1. J Immunother 33:443\u2013452. https:\/\/doi.org\/10.1097\/CJI.0b013e3181cd8746","journal-title":"J Immunother"},{"key":"4335_CR163","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","volume":"24","author":"TL Lam","year":"2011","unstructured":"Lam TL, Wong GKY, Chow HY et al (2011) Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis. Pigm Cell Melanoma Res 24:366\u2013376. https:\/\/doi.org\/10.1111\/j.1755-148X.2010.00798.x","journal-title":"Pigm Cell Melanoma Res"},{"key":"4335_CR164","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00253-013-5118-0","volume":"98","author":"Z Wang","year":"2014","unstructured":"Wang Z, Shi X, Li Y et al (2014) Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells. Appl Microbiol Biotechnol 98:2485\u20132494. https:\/\/doi.org\/10.1007\/s00253-013-5118-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"4335_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054464","volume":"8","author":"JW Wells","year":"2013","unstructured":"Wells JW, Evans CH, Scott MC et al (2013) Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. PLoS ONE 8:e54464. https:\/\/doi.org\/10.1371\/journal.pone.0054464","journal-title":"PLoS ONE"},{"key":"4335_CR166","doi-asserted-by":"publisher","first-page":"e1563","DOI":"10.1038\/cddis.2014.503","volume":"5","author":"Z Wang","year":"2014","unstructured":"Wang Z, Shi X, Li Y et al (2014) Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells. Cell Death Dis 5:e1563\u2013e1563. https:\/\/doi.org\/10.1038\/cddis.2014.503","journal-title":"Cell Death Dis"},{"key":"4335_CR167","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1007\/s00253-015-6565-6","volume":"99","author":"C Lin","year":"2015","unstructured":"Lin C, Wang Z, Li L et al (2015) The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol 99:8487\u20138494. https:\/\/doi.org\/10.1007\/s00253-015-6565-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"4335_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118674","volume":"264","author":"KM Yu","year":"2021","unstructured":"Yu KM, Pang TP, Cutler M et al (2021) Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment. Life Sci 264:118674. https:\/\/doi.org\/10.1016\/j.lfs.2020.118674","journal-title":"Life Sci"},{"key":"4335_CR169","doi-asserted-by":"publisher","first-page":"5510663","DOI":"10.1155\/2021\/5510663","volume":"2021","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang P, Li W et al (2021) Pegylated recombinant human arginase 1 induces autophagy and apoptosis via the ROS-activated AKT\/mTOR pathway in bladder cancer cells. Oxid Med Cell Longev 2021:5510663. https:\/\/doi.org\/10.1155\/2021\/5510663","journal-title":"Oxid Med Cell Longev"},{"key":"4335_CR170","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13048-021-00767-3","volume":"14","author":"N El-Mais","year":"2021","unstructured":"El-Mais N, Fakhoury I, Abdellatef S et al (2021) Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA. J Ovarian Res 14:13. https:\/\/doi.org\/10.1186\/s13048-021-00767-3","journal-title":"J Ovarian Res"},{"key":"4335_CR171","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2004.10.050","volume":"224","author":"PNM Cheng","year":"2005","unstructured":"Cheng PNM, Leung YC, Lo WH et al (2005) Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma. Cancer Lett 224:67\u201380. https:\/\/doi.org\/10.1016\/j.canlet.2004.10.050","journal-title":"Cancer Lett"},{"key":"4335_CR172","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10637-012-9807-9","volume":"31","author":"T Yau","year":"2013","unstructured":"Yau T, Cheng PN, Chan P et al (2013) A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Invest New Drugs 31:99\u2013107. https:\/\/doi.org\/10.1007\/s10637-012-9807-9","journal-title":"Invest New Drugs"},{"key":"4335_CR173","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/annonc\/mdx261.141","volume":"28","author":"T Yau","year":"2017","unstructured":"Yau T, Chiu J, Ng Chi T et al (2017) A phase 1 study of recombinant human arginase 1 (PEG-BCT-100) in combination with capecitabine and oxaliplatin in advanced hepatocellular carcinoma patients. Ann Oncol 28:54. https:\/\/doi.org\/10.1093\/annonc\/mdx261.141","journal-title":"Ann Oncol"},{"key":"4335_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0612-6","volume":"11","author":"C De Santo","year":"2018","unstructured":"De Santo C, Cheng P et al (2018) Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma. J hemato oncol 11:1\u20135. https:\/\/doi.org\/10.1186\/s13045-018-0612-6","journal-title":"J hemato oncol"},{"key":"4335_CR175","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01111-8","author":"SL Chan","year":"2021","unstructured":"Chan SL, Cheng PNM, Liu AM et al (2021) A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma. Invest New Drugs. https:\/\/doi.org\/10.1007\/s10637-021-01111-8","journal-title":"Invest New Drugs"},{"key":"4335_CR176","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1093\/hmg\/ddv352","volume":"24","author":"LC Burrage","year":"2015","unstructured":"Burrage LC, Sun Q, Elsea SH et al (2015) Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. Hum Mol Genet 24:6417\u20136427. https:\/\/doi.org\/10.1093\/hmg\/ddv352","journal-title":"Hum Mol Genet"},{"key":"4335_CR177","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2020.12.041","volume":"502","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chung S-F, Tam S-Y et al (2021) Arginine deprivation as a strategy for cancer therapy: an insight into drug design and drug combination. Cancer Lett 502:58\u201370. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.041","journal-title":"Cancer Lett"},{"key":"4335_CR178","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ijc.30051","volume":"139","author":"L Fultang","year":"2016","unstructured":"Fultang L, Vardon A, De Santo C, Mussai F (2016) Molecular basis and current strategies of therapeutic arginine depletion for cancer. Int J Cancer 139:501\u2013509. https:\/\/doi.org\/10.1002\/ijc.30051","journal-title":"Int J Cancer"},{"key":"4335_CR179","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbapap.2018.08.006","volume":"1866","author":"V Sadarangani","year":"2018","unstructured":"Sadarangani V, Rahman S, Sau AK (2018) Metal ions-induced stability and function of bimetallic human arginase-I, a therapeutically important enzyme. Biochim Biophys Acta 1866:1153\u20131164. https:\/\/doi.org\/10.1016\/j.bbapap.2018.08.006","journal-title":"Biochim Biophys Acta"},{"key":"4335_CR180","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/423129","author":"L Li","year":"2013","unstructured":"Li L, Wang Y, Chen J et al (2013) An engineered arginase FC protein inhibits tumor growth in vitro and in vivo. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2013\/423129","journal-title":"Evid Based Complement Alternat Med"},{"key":"4335_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2021.100910","volume":"25","author":"M Suman","year":"2021","unstructured":"Suman M, Rajnikant M (2021) Impact of suitable control on a uniform interpretation of units for arginase assay. Biochem Biophys Rep 25:100910. https:\/\/doi.org\/10.1016\/j.bbrep.2021.100910","journal-title":"Biochem Biophys Rep"},{"key":"4335_CR182","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/j.1432-1033.2004.04105.x","volume":"271","author":"DJ McGee","year":"2004","unstructured":"McGee DJ, Zabaleta J, Viator RJ et al (2004) Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J Biochem 271:1952\u20131962. https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04105.x","journal-title":"Eur J Biochem"},{"key":"4335_CR183","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/cbin.10383","volume":"39","author":"OV Stasyk","year":"2015","unstructured":"Stasyk OV, Boretsky YR, Gonchar MV, Sibirny AA (2015) Recombinant arginine-degrading enzymes in metabolic anticancer therapy and bioanalytics. Cell Biol Int 39:246\u2013252. https:\/\/doi.org\/10.1002\/cbin.10383","journal-title":"Cell Biol Int"},{"key":"4335_CR184","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.saa.2017.12.031","volume":"193","author":"N Stasyuk","year":"2018","unstructured":"Stasyuk N, Gayda G, Zakalskiy A et al (2018) Highly selective apo-arginase based method for sensitive enzymatic assay of manganese (II) and cobalt (II) ions. Spectrochim Acta A Mol Biomol Spectrosc 193:349\u2013356. https:\/\/doi.org\/10.1016\/j.saa.2017.12.031","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"4335_CR185","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/cncr.20057","volume":"100","author":"BJ Dillon","year":"2004","unstructured":"Dillon BJ, Prieto VG, Curley SA et al (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers. Cancer 100:826\u2013833. https:\/\/doi.org\/10.1002\/cncr.20057","journal-title":"Cancer"},{"key":"4335_CR186","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/07391102.2018.1431151","volume":"37","author":"M Zarei","year":"2019","unstructured":"Zarei M, Nezafat N, Rahbar MR et al (2019) Decreasing the immunogenicity of arginine deiminase enzyme via structure-based computational analysis. J Biomol Struct Dyn 37:523\u2013536. https:\/\/doi.org\/10.1080\/07391102.2018.1431151","journal-title":"J Biomol Struct Dyn"},{"key":"4335_CR187","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4143\/crt.2013.45.4.251","volume":"45","author":"MM Phillips","year":"2013","unstructured":"Phillips MM, Sheaff MT, Szlosarek PW (2013) Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges. Cancer Res Treat 45:251\u2013262. https:\/\/doi.org\/10.4143\/crt.2013.45.4.251","journal-title":"Cancer Res Treat"},{"key":"4335_CR188","doi-asserted-by":"publisher","first-page":"246","DOI":"10.18632\/oncotarget.135","volume":"1","author":"MT Kuo","year":"2010","unstructured":"Kuo MT, Savaraj N, Feun LG (2010) Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget 1:246\u2013251. https:\/\/doi.org\/10.18632\/oncotarget.135","journal-title":"Oncotarget"},{"key":"4335_CR189","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/bj3630581","volume":"363","author":"JB Thomas","year":"2002","unstructured":"Thomas JB, Holtsberg FW, Ensor CM et al (2002) Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor \u03b1 and endotoxin. Biochem J 363:581\u2013587. https:\/\/doi.org\/10.1042\/bj3630581","journal-title":"Biochem J"},{"key":"4335_CR190","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0165-6147(00)01499-1","volume":"21","author":"M Colasanti","year":"2000","unstructured":"Colasanti M, Suzuki H (2000) The dual personality of NO. Trends Pharmacol Sci 21:249\u2013252. https:\/\/doi.org\/10.1016\/S0165-6147(00)01499-1","journal-title":"Trends Pharmacol Sci"},{"key":"4335_CR191","first-page":"BR248","volume":"8","author":"BJ Dillon","year":"2002","unstructured":"Dillon BJ, Holtsberg FW, Ensor CM et al (2002) Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit 8:BR248-253","journal-title":"Med Sci Monit"},{"key":"4335_CR192","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.job.2020.12.002","volume":"63","author":"LV Bel\u2019skaya","year":"2021","unstructured":"Bel\u2019skaya LV, Sarf EA, Kosenok VK (2021) Indicators of L-arginine metabolism in saliva: a focus on breast cancer. J Oral Biosci 63:52\u201357. https:\/\/doi.org\/10.1016\/j.job.2020.12.002","journal-title":"J Oral Biosci"},{"key":"4335_CR193","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.procbio.2013.02.023","volume":"48","author":"T Zhang","year":"2013","unstructured":"Zhang T, Guo Y, Zhang H et al (2013) Arginase from Bacillus thuringiensis SK 20.001: purification, characteristics, and implications for L-ornithine biosynthesis. Process Biochem 48:663\u2013668. https:\/\/doi.org\/10.1016\/j.procbio.2013.02.023","journal-title":"Process Biochem"},{"key":"4335_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcatb.2014.09.005","volume":"110","author":"W Song","year":"2014","unstructured":"Song W, Niu P, Chen X, Liu L (2014) Enzymatic production of L-ornithine from L-arginine with recombinant thermophilic arginase. J Mol Catal B: Enzym 110:1\u20137. https:\/\/doi.org\/10.1016\/j.molcatb.2014.09.005","journal-title":"J Mol Catal B: Enzym"},{"key":"4335_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12896-015-0184-2","volume":"15","author":"X Zhang","year":"2015","unstructured":"Zhang X, Liu J, Yu X et al (2015) High-level expression of human arginase I in Pichia pastoris and its immobilization on chitosan to produce L-ornithine. BMC Biotechnol 15:1\u201310. https:\/\/doi.org\/10.1186\/s12896-015-0184-2","journal-title":"BMC Biotechnol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-021-04335-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T06:04:47Z","timestamp":1629093887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-021-04335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":195,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1007\/s00280-021-04335-w","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}